Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Synopsys Posts Financial Results for Second Quarter Fiscal Year 2025

      Synopsys (PRNewsfoto/Synopsys)

      News provided by

      Synopsys, Inc.

      May 28, 2025, 16:05 ET

      Share this article

      Share this article


      Results Summary

      • Quarterly revenue of $1.604 billion, exceeding midpoint of guidance.
      • Quarterly GAAP earnings per diluted share of $2.24; non-GAAP earnings per diluted share of $3.67, exceeding guidance.
      • Reaffirming full-year 2025 revenue guidance, and non-GAAP operating margin guidance.

      SUNNYVALE, Calif., May 28, 2025 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its second quarter of fiscal year 2025. Revenue for the second quarter of fiscal year 2025 was $1.604 billion, compared to $1.455 billion for the second quarter of fiscal year 2024.

      Continue Reading
      Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)
      Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)

      "We delivered a strong quarter, which demonstrates the mission-critical nature of our products and the resiliency of our business," said Sassine Ghazi, president and CEO of Synopsys. "The mega trends of AI, software-defined systems, and silicon proliferation continue to drive our growth. These trends are increasing design complexity and costs, while also increasing compute performance and energy demands. Synopsys is a trusted partner in addressing these challenges and a leader in applying AI to help customers innovate faster."

      "In a dynamic macro environment, Synopsys continues to execute with strong Q2 results on the top and bottom line," said Shelagh Glaser, CFO of Synopsys. "We're poised to deliver a solid second half, and we're reaffirming our full-year revenue and operating margin guidance, reflecting our confidence in the business and continued healthy demand for our products."

      Continuing Operations 
      On September 30, 2024, Synopsys completed the sale of its Software Integrity business. Unless otherwise noted, Synopsys' Software Integrity business has been presented as a discontinued operation in the Synopsys' consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis.

      GAAP Results
      On a U.S. generally accepted accounting principles (GAAP) basis, net income for the second quarter of fiscal year 2025 was $349.2 million, or $2.24 per diluted share, compared to $299.1 million, or $1.92 per diluted share, for the second quarter of fiscal year 2024.

      Non-GAAP Results
      On a non-GAAP basis, net income for the second quarter of fiscal year 2025 was $572.7 million, or $3.67 per diluted share, compared to non-GAAP net income of $466.9 million, or $3.00 per diluted share, for the second quarter of fiscal year 2024.

      For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below.

      Business Segments 
      Synopsys reports revenue and operating income in two segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array IC design software, verification software and hardware products, manufacturing software products and other and (2) Design IP, which includes our interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services.

      Financial Targets
      Synopsys also provided its consolidated financial targets for the third quarter and full fiscal year 2025. These targets reflect a change in Synopsys' fiscal year from a 52/53-week period ending on the Saturday nearest to October 31 of each year to October 31 of each year. As a result of this change, there will be ten fewer days in the first half of fiscal year 2025 and two extra days in the second half of fiscal year 2025, which results in eight fewer days in the aggregate in Synopsys' fiscal year 2025 as compared to its fiscal year 2024. These targets also assume no further changes to export control restrictions or the current U.S. government "Entity List" restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see "Forward-Looking Statements" below. 

      Third Quarter and Full Fiscal Year 2025 Financial Targets (1)

      (in millions except per share amounts)








       Range for Three Months Ending


      Range for Fiscal Year Ending


      July 31, 2025


      October 31, 2025


      Low

      High


      Low

      High

      Revenue

      $              1,755

      $              1,785


      $              6,745

      $              6,805

      GAAP Expenses

      $              1,273

      $              1,293


      $              5,011

      $              5,068

      Non-GAAP Expenses

      $              1,055

      $              1,065


      $              4,045

      $              4,085

      Non-GAAP Interest and Other Income
      (Expense), net

      $                     9

      $                   11


      $                 118

      $                 122

      Non-GAAP Tax Rate

      16 %

      16 %


      16 %

      16 %

      Outstanding Shares (fully diluted)

      156

      158


      156

      158

      GAAP EPS

      $                2.63

      $                2.74


      $              10.14

      $              10.34

      Non-GAAP EPS

      $                3.82

      $                3.87


      $              15.11

      $              15.19

      Operating Cash Flow




      ~$1,500

      Free Cash Flow(2)




      ~$1,300

      Capital Expenditures




      ~$170







      (1) Targets do not reflect the impact of any future financing transactions related to the Ansys Merger (as defined

      below) or targets for the combined company.

      (2) Free cash flow is calculated as cash provided from operating activities less capital expenditures.

      For a reconciliation of Synopsys' third quarter and fiscal year 2025 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis and a discussion of the financial targets that we are not able to reconcile without unreasonable efforts, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below.

      Earnings Call Open to Investors
      Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys' corporate website at investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the third quarter of fiscal year 2025.

      Effectiveness of Information
      The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys' corporate website at www.synopsys.com (collectively, the "Earnings Materials"), represent Synopsys' expectations and beliefs as of May 28, 2025. Although these Earnings Materials will remain available on Synopsys' website through the date of the earnings call for the third quarter of fiscal year 2025, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

      Availability of Final Financial Statements
      Synopsys will include final financial statements for the second quarter of fiscal year 2025 in its quarterly report on Form 10-Q to be filed on or before June 9, 2025.

      Reconciliation of Second Quarter Fiscal Year 2025 Results
      The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income, earnings per diluted share, and tax rate for the periods indicated below.

      GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2025 Results(1)

      (unaudited and in thousands, except per share amounts)










      Three Months Ended


      Six Months Ended


      April 30,


      April 30,


      2025


      2024


      2025


      2024

      GAAP net income from continuing operations attributed to Synopsys

      $               349,232


      $       299,111


      $       644,915


      $       736,561

      Adjustments:








      Amortization of acquired intangible assets

      11,656


      16,925


      24,252


      32,526

      Stock-based compensation

      201,723


      162,346


      388,002


      327,487

      Acquisition/divestiture related items

      69,514


      25,256


      144,343


      57,188

      (Gain) loss on sale of strategic investments

      2,435


      —


      2,435


      (55,077)

      Tax adjustments

      (61,862)


      (36,694)


      (158,076)


      (106,261)

      Non-GAAP net income from continuing operations attributed to Synopsys

      $               572,698


      $       466,944


      $    1,045,871


      $       992,424


























      Three Months Ended


      Six Months Ended


      April 30,


      April 30,


      2025


      2024


      2025


      2024

      GAAP net income from continuing operations per diluted share attributed to Synopsys

      $                      2.24


      $              1.92


      $              4.13


      $              4.73

      Adjustments:








      Amortization of acquired intangible assets

      0.07


      0.11


      0.16


      0.21

      Stock-based compensation

      1.29


      1.04


      2.48


      2.10

      Acquisition/divestiture related items

      0.45


      0.16


      0.92


      0.37

      (Gain) loss on sale of strategic investments

      0.02


      —


      0.02


      (0.35)

      Tax adjustments

      (0.40)


      (0.23)


      (1.02)


      (0.68)

      Non-GAAP net income from continuing operations per diluted share attributed to Synopsys

      $                      3.67


      $              3.00


      $              6.69


      $              6.38

















      Shares used in computing net income per diluted share amounts:

      156,088


      155,770


      156,218


      155,610









      (1) Synopsys' second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation

      purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the
      first quarter.

      GAAP to Non-GAAP Tax Rate Reconciliation (1)

      (unaudited)





      Three Months Ended

      Six Months Ended


      April 30, 2025

      April 30, 2025

      GAAP effective tax rate

      11.9 %

      5.9 %

      Stock-based compensation

      (0.5) %

      1.5 %

      Acquisition/divestiture related items (2)

      0.9 %

      5.4 %

      Tax adjustments (3)

      3.7 %

      3.2 %

      Non-GAAP effective tax rate

      16.0 %

      16.0 %




      (1) Presented on a continuing operations basis.

      (2) The adjustment is primarily due to the capital loss on the sale of Synopsys' ownership in OpenLight

      Photonics, Inc.

      (3) The adjustments are primarily related to the differences in the tax rate effect of certain deductions, such as the

      deduction for foreign-derived intangible income and credits.

      Reconciliation of 2025 Targets
      The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

      GAAP to Non-GAAP Reconciliation of Third Quarter Fiscal Year 2025 Targets

      (in thousands, except per share amounts)











       Range for Three Months Ending



      July 31, 2025



      Low


      High

      Target GAAP expenses


      $          1,273,000


      $          1,293,000

      Adjustments:





            Amortization of acquired intangible assets


      (11,000)


      (14,000)

            Stock-based compensation


      (207,000)


      (214,000)

      Target non-GAAP expenses


      $          1,055,000


      $          1,065,000
















      Range for Three Months Ending



      July 31, 2025



      Low


      High

      Target GAAP earnings per diluted share attributed to Synopsys


      $                    2.63


      $                    2.74

      Adjustments:





            Amortization of acquired intangible assets


      0.09


      0.07

            Stock-based compensation


      1.36


      1.32

            Acquisition/divestiture related items (1)


      0.01


      —

            Tax adjustments


      (0.27)


      (0.26)

      Target non-GAAP earnings per diluted share attributed to Synopsys


      $                    3.82


      $                    3.87






      Shares used in non-GAAP calculation (midpoint of target range)


      157,000


      157,000

      GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2025 Targets

      (in thousands, except per share amounts)











      Range for Fiscal Year Ending



      October 31, 2025



      Low


      High

      Target GAAP expenses


      $          5,011,252


      $          5,068,252

      Adjustments:





            Amortization of acquired intangible assets


      (46,000)


      (51,000)

            Stock-based compensation


      (820,000)


      (832,000)

            Acquisition/divestiture related items (1)


      (100,252)


      (100,252)

      Target non-GAAP expenses


      $          4,045,000


      $          4,085,000
















      Range for Fiscal Year Ending



      October 31, 2025



      Low


      High

      Target GAAP earnings per diluted share attributed to Synopsys


      $                  10.14


      $                  10.34

      Adjustments:





            Amortization of acquired intangible assets


      0.32


      0.29

            Stock-based compensation


      5.30


      5.22

            Acquisition/divestiture related items (1)


      0.93


      0.92

            Gain on sale of strategic investments


      0.02


      0.02

            Tax adjustments


      (1.60)


      (1.60)

      Target non-GAAP earnings per diluted share attributed to Synopsys


      $                  15.11


      $                  15.19






      Shares used in non-GAAP calculation (midpoint of target range)


      157,000


      157,000






      (1)  Adjustments reflect actual expenses incurred by Synopsys as of April 30, 2025 or certain contractually
      obligated financing fees and related amortization expenses, and do not fully reflect all potential adjustments

      for future periods for the reasons set forth in "GAAP to Non-GAAP Reconciliation" below.

      Forward-Looking Statements
      This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding short-term and long-term financial targets, expectations and objectives including, among others, our long-term financial objectives, which include the anticipated effects of our pending acquisition of ANSYS, Inc. (the Ansys Merger); our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; the Ansys Merger, including, among other things, the anticipated timing of closing, the status of the related regulatory approvals, and its expected impact; planned dispositions and their expected impact; the potential impact of the uncertain macroeconomic environment on our financial results, including, but not limited to, the effects of sustained global inflationary pressures and elevated interest rates, potential economic slowdowns or recessions, supply chain disruptions, geopolitical pressures, including, among others, the unknown impact of current and future U.S. and foreign trade regulations, government actions and regulatory changes, such as export control restrictions and tariffs, and regional or global military conflicts, and fluctuations in foreign exchange rates, and associated global economic conditions; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; the expected realization of our contracted but unsatisfied or partially unsatisfied performance obligations (backlog); software trends; planned stock repurchases; our expected tax rate; and the impact and result of pending legal, regulatory, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; failure to complete the Ansys Merger on the terms described in our filings with the SEC, if at all; failure to obtain required governmental approvals related to the Ansys Merger or the imposition of conditions to such governmental approvals that may have an adverse effect on us; failure to realize the benefits expected from the Ansys Merger; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys' results is included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys' most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys' financial results for its second quarter of fiscal year 2025 are not necessarily indicative of Synopsys' operating results for any future periods. The information provided herein is as of May 28, 2025. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

      SYNOPSYS, INC.

      Unaudited Condensed Consolidated Statements of Income (1)

      (in thousands, except per share amounts)


















      Three Months Ended


      Six Months Ended


      April 30,


      April 30,


      2025


      2024


      2025


      2024

      Revenue:








        Time-based products

      $                828,326


      $                781,714


      $             1,656,564


      $             1,586,777

        Upfront products

      510,676


      396,389


      878,800


      838,755

          Total products revenue

      1,339,002


      1,178,103


      2,535,364


      2,425,532

        Maintenance and service

      265,264


      276,609


      524,217


      540,169

            Total revenue

      1,604,266


      1,454,712


      3,059,581


      2,965,701

      Cost of revenue:








        Products

      216,216


      198,719


      385,058


      374,217

        Maintenance and service

      94,471


      88,178


      187,008


      178,718

        Amortization of acquired intangible assets

      7,660


      13,500


      16,256


      26,655

            Total cost of revenue

      318,347


      300,397


      588,322


      579,590

      Gross margin

      1,285,919


      1,154,315


      2,471,259


      2,386,111

      Operating expenses:








        Research and development

      553,979


      493,136


      1,107,195


      1,018,670

        Sales and marketing

      215,021


      209,783


      424,220


      428,626

        General and administrative

      136,497


      114,763


      303,583


      246,027

        Amortization of acquired intangible assets

      3,996


      4,561


      7,996


      8,090

            Total operating expenses

      909,493


      822,243


      1,842,994


      1,701,413

      Operating income

      376,426


      332,072


      628,265


      684,698

      Interest expense

      (94,336)


      (7,067)


      (105,475)


      (8,805)

      Other income (expense), net

      114,101


      16,525


      164,518


      123,091

      Income before income taxes

      396,191


      341,530


      687,308


      798,984

      Provision (benefit) for income taxes

      47,181


      45,437


      40,887


      68,346

      Net income from continuing operations

      349,010


      296,093


      646,421


      730,638

      Income (loss) from discontinued operations, net of

      income taxes

      (3,900)


      (7,004)


      (3,900)


      4,658

      Net income

      345,110


      289,089


      642,521


      735,296

      Less: Net income (loss) attributed to non-controlling

      interest and redeemable non-controlling interest

      (222)


      (3,018)


      1,506


      (5,923)

      Net income attributed to Synopsys

      $                345,332


      $                292,107


      $                641,015


      $                741,219









      Net income (loss) attributed to Synopsys








       Continuing operations

      $                349,232


      $                299,111


      $                644,915


      $                736,561

       Discontinued operations

      (3,900)


      (7,004)


      (3,900)


      4,658

       Net income

      $                345,332


      $                292,107


      $                641,015


      $                741,219









      Net income (loss) per share attributed to Synopsys - basic:








        Continuing operations

      $                      2.25


      $                      1.96


      $                      4.17


      $                      4.83

        Discontinued operations

      (0.02)


      (0.05)


      (0.03)


      0.03

        Basic net income per share

      $                      2.23


      $                      1.91


      $                      4.14


      $                      4.86









      Net income (loss) per share attributed to Synopsys - diluted:








        Continuing operations

      $                      2.24


      $                      1.92


      $                      4.13


      $                      4.73

        Discontinued operations

      (0.03)


      (0.04)


      (0.03)


      0.03

        Diluted net income per share

      $                      2.21


      $                      1.88


      $                      4.10


      $                      4.76









      Shares used in computing per share amounts:








        Basic

      154,927


      152,971


      154,666


      152,629

        Diluted

      156,088


      155,770


      156,218


      155,610









      (1) Synopsys' second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation purposes,

      we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

      SYNOPSYS, INC.


      Unaudited Condensed Consolidated Balance Sheets (1)


      (in thousands, except par value amounts)










      April 30, 2025


      October 31, 2024


      ASSETS:






      Current assets:






        Cash and cash equivalents


      $           14,119,095


      $             3,896,532


        Short-term investments


      144,816


      153,869


                Total cash, cash equivalents and short-term investments


      14,263,911


      4,050,401


        Accounts receivable, net


      1,002,195


      934,470


        Inventories


      395,339


      361,849


        Prepaid and other current assets


      1,217,584


      1,122,946


                Total current assets


      16,879,029


      6,469,666


      Property and equipment, net


      571,982


      563,006


      Operating lease right-of-use assets, net


      585,704


      565,917


      Goodwill


      3,461,272


      3,448,850


      Intangible assets, net


      173,394


      195,164


      Deferred income taxes


      1,509,159


      1,247,258


      Other long-term assets


      575,977


      583,700


                 Total assets


      $           23,756,517


      $           13,073,561








      LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND

      STOCKHOLDERS' EQUITY:






      Current liabilities:






        Accounts payable and accrued liabilities


      $                903,546


      $             1,163,592


        Operating lease liabilities


      104,170


      94,791


        Deferred revenue


      1,375,398


      1,391,737


        Short-term debt


      22,962


      —


                 Total current liabilities


      2,406,076


      2,650,120


      Long-term operating lease liabilities


      587,438


      574,065


      Long-term deferred revenue


      331,133


      340,831


      Long-term debt


      10,027,681


      15,601


      Other long-term liabilities


      488,584


      469,738


                 Total liabilities


      13,840,912


      4,050,355


      Redeemable non-controlling interest


      —


      30,000


      Stockholders' equity:






        Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding


      —


      —


        Common stock, $0.01 par value: 400,000 shares authorized; 155,146 and 154,112

      shares outstanding, respectively


      1,552


      1,541


        Capital in excess of par value


      1,219,021


      1,211,206


        Retained earnings


      9,624,282


      8,984,105


        Treasury stock, at cost: 2,115 and 3,148 shares, respectively


      (689,001)


      (1,025,770)


        Accumulated other comprehensive income (loss)


      (240,136)


      (180,380)


                 Total Synopsys stockholders' equity


      9,915,718


      8,990,702


      Non-controlling interest


      (113)


      2,504


                 Total stockholders' equity


      9,915,605


      8,993,206


                 Total liabilities, redeemable non-controlling interest and stockholders' equity


      $           23,756,517


      $           13,073,561








      (1) Synopsys' second quarter of fiscal year 2025 ended on April 30, 2025 and its fiscal year 2024 ended on November 2, 2024,

       respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year,

      which included an extra week in the first quarter.



      SYNOPSYS, INC.

      Unaudited Condensed Consolidated Statements of Cash Flows (1)

      (in thousands)






      Six Months Ended April 30,


      2025


      2024

      CASH FLOWS FROM OPERATING ACTIVITIES:




      Net income

      $                642,521


      $                735,296

      Adjustments to reconcile net income to net cash provided by operating activities:




      Amortization and depreciation

      96,838


      123,886

      Reduction of operating lease right-of-use assets

      51,728


      48,179

      Amortization of capitalized costs to obtain revenue contracts

      25,405


      37,912

      Stock-based compensation

      388,186


      358,487

      Allowance for credit losses

      15,940


      9,987

      (Gain) loss on sale of strategic investments

      2,435


      (55,077)

      Gain on sale of building

      (51,385)


      —

      Loss on divestitures, net of transaction costs

      8,299


      —

      Amortization of bridge financing costs

      40,411


      7,085

      Amortization of debt issuance costs

      2,348


      —

      Deferred income taxes

      (237,170)


      (170,854)

      Other

      (181)


      (2,607)

      Net changes in operating assets and liabilities, net of effects from

      acquisitions and dispositions:




      Accounts receivable

      (74,098)


      20,889

      Inventories

      (39,766)


      (60,518)

      Prepaid and other current assets

      (140,472)


      (191,595)

      Other long-term assets

      (36,058)


      (104,551)

      Accounts payable and accrued liabilities

      (242,529)


      (142,086)

      Operating lease liabilities

      (48,617)


      (48,709)

      Income taxes

      (36,870)


      (229,536)

      Deferred revenue

      (37,412)


      52,612

      Unrealized loss on settlement of interest rate treasury lock

      (121,643)


      —

      Net cash provided by operating activities

      207,910


      388,800





      CASH FLOWS FROM INVESTING ACTIVITIES:




      Proceeds from maturities of short-term investments

      35,461


      63,159

      Proceeds from sales of short-term investments

      22,015


      —

      Purchases of short-term investments

      (47,558)


      (65,861)

      Proceeds from sales of strategic investments

      —


      55,696

      Purchases of strategic investments

      (3,368)


      (860)

      Purchases of property and equipment, net

      (96,303)


      (78,763)

      Proceeds from sale of building

      74,279


      —

      Acquisitions, net of cash acquired

      —


      (139,557)

      Proceeds from business divestiture, net of cash divested

      70,082


      —

      Other

      (611)


      —

      Net cash provided by (used in) investing activities

      53,997


      (166,186)





      CASH FLOWS FROM FINANCING ACTIVITIES:




      Proceeds from debt, net of issuance costs

      10,034,464


      —

      Repayments on debt and credit facilities

      (1,289)


      (1,303)

      Payment of bridge financing and term loan costs

      —


      (54,715)

      Issuances of common stock

      118,308


      115,111

      Payments for taxes related to net share settlement of equity awards

      (166,872)


      (212,577)

      Redemption of redeemable non-controlling interest

      (30,000)


      —

      Other

      —


      (1,096)

      Net cash provided by (used in) financing activities

      9,954,611


      (154,580)

      Effect of exchange rate changes on cash, cash equivalents and restricted cash

      8,186


      2,423

      Net change in cash, cash equivalents and restricted cash

      10,224,704


      70,457

      Cash, cash equivalents and restricted cash, beginning of year, including cash
      from discontinued operations

      3,898,729


      1,441,187

      Cash, cash equivalents and restricted cash, end of period, including cash
      from discontinued operations

      14,123,433


      1,511,644

      Less: Cash, cash equivalents and restricted cash from discontinued operations

      —


      6,445

      Cash, cash equivalents and restricted cash from continuing operations

      $           14,123,433


      $             1,505,199





      (1) Synopsys' second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For

      presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included

      an extra week in the first quarter.

      Synopsys provides segment information, namely revenue, adjusted segment operating income and adjusted segment operating margin, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 280, Segment Reporting. Synopsys' chief operating decision maker ("CODM") is our Chief Executive Officer. In evaluating our business segments, the CODM considers the income and expenses that the CODM believes are directly related to those segments. The CODM does not allocate certain operating expenses managed at a consolidated level to our business segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table below. These unallocated expenses are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income from continuing operations:

      SYNOPSYS, INC.

      Business Segment Reporting (1)(2)

      (in millions)










      Three Months Ended

      April 30, 2025


      Three Months Ended
      April 30, 2024


      Six Months Ended

      April 30, 2025


      Six Months Ended

      April 30, 2024





      Revenue by segment








      - Design Automation

      $                    1,122.3


      $                     1,054.9


      $                     2,142.5


      $                     2,040.3

      % of Total

      70.0 %


      72.5 %


      70.0 %


      68.8 %

      - Design IP

      $                       482.0


      $                        399.8


      $                        917.1


      $                        925.4

      % of Total

      30.0 %


      27.5 %


      30.0 %


      31.2 %









      Adjusted operating income by segment








      - Design Automation

      $                       458.8


      $                        418.2


      $                        863.4


      $                        777.7

      - Design IP

      $                       150.5


      $                        124.8


      $                        277.1


      $                        370.5









      Adjusted operating margin by segment








      - Design Automation

      40.9 %


      39.6 %


      40.3 %


      38.1 %

      - Design IP

      31.2 %


      31.2 %


      30.2 %


      40.0 %

      Total Adjusted Segment Operating Income Reconciliation (1)(2)

      (in millions)










      Three Months Ended

      April 30, 2025


      Three Months Ended

      April 30, 2024


      Six Months Ended

      April 30, 2025


      Six Months Ended

       April 30, 2024





      GAAP total operating income – as reported

      $                          376.4


      $                          332.1


      $                          628.3


      $                          684.7

      Other expenses managed at consolidated level








      -Amortization of acquired intangible assets (3)

      11.7


      18.1


      24.3


      34.7

      -Stock-based compensation (3)

      201.7


      162.7


      388.2


      328.2

      -Non-qualified deferred compensation plan

      (20.1)


      11.1


      (0.5)


      50.5

      -Acquisition/divestiture related items (4)

      39.6


      19.2


      100.3


      50.1

      Total adjusted segment operating income

      $                          609.3


      $                          543.0


      $                       1,140.5


      $                       1,148.2









      (1) Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our
      business. Amounts may not foot due to rounding.

      (2) Synopsys' second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation purposes, we refer to

      the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

      (3) The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

      (4) The adjustment excludes the amortization of bridge financing costs entered into in connection with the pending Ansys Merger that was recorded in

      interest expense, and certain divestiture related items that were recorded in other income (expense), net in our unaudited condensed consolidated statements
      of income. 

      GAAP to Non-GAAP Reconciliation
      Synopsys continues to provide all information required in accordance with GAAP but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. This press release includes non-GAAP earnings per diluted share, non-GAAP net income and non-GAAP tax rate for the periods presented. It also includes future estimates for non-GAAP expenses, non-GAAP interest and other income (expense), non-GAAP tax rate, non-GAAP earnings per diluted share and free cash flow. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

      When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Synopsys is unable to provide a full reconciliation of certain third quarter and full fiscal year 2025 non-GAAP financial targets to the corresponding GAAP financial measures on a forward-looking basis because Synopsys believes that it would not be possible for it to have the required information necessary to quantitatively reconcile such measures with sufficient precision without unreasonable efforts due to, among other things, the potential variability and limited predictability of the excluded adjustment items necessary for a full reconciliation such as certain acquisition/divestiture related items, restructuring charges, tax deduction variability, changes in the fair value of non-qualified deferred compensation plan, and gains (losses) on the sale of strategic investments. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information. 

      Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, the corresponding GAAP financial measures. Synopsys' management believes presentation of non-GAAP financial measures, when shown in conjunction with the corresponding GAAP financial measures, provides useful information to investors allowing them to view financial and business trends relating to our financial condition and results of operations through the eyes of management. Synopsys' management evaluates and makes decisions about our business operations using both GAAP financial measures and non-GAAP financial measures to help facilitate internal comparisons to Synopsys' historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors' operating results.

      The following are descriptions of the adjustments made to reconcile non-GAAP financial measures (other than free cash flow, which is defined in the footnote to the Financial Targets table above) to the most directly comparable GAAP financial measures:

      (i) Amortization of acquired intangible assets. We incur expenses from amortization of acquired intangible assets, which may include impairment charges from write-downs of acquired intangible assets. Acquired intangible assets include, among other things, core/developed technology, customer relationships, contract rights, trademarks and trade names, and other intangibles related to acquisitions. We amortize the intangible assets over their estimated useful lives. We do not enter into acquisitions on a predictable cycle. The amount of an acquisition's purchase price allocated to intangible assets and their estimated useful lives can vary significantly and are unique to each acquisition. From time to time, we incur impairment charges due to write-downs of acquired intangible assets. We believe that the presentation of non-GAAP financial measures that adjust for the amortization of intangible assets, including impairment charges, provides investors and others with a consistent basis for comparison across accounting periods. We also exclude this item because such expenses are non-cash in nature and we believe the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding our core operational performance and liquidity, and ability to invest in research and development and fund future acquisitions and capital expenditures.

      (ii) Stock-based compensation. Stock-based compensation expenses consist primarily of expenses related to restricted stock units, stock options, employee stock purchase rights and other stock awards, including such expenses associated with acquisitions. We exclude stock-based compensation expense from our non-GAAP financial measures primarily because it is not an expense that typically requires or will require cash settlement by us. Further, the expense for the fair value of the stock-based instruments we utilize may bear little resemblance to the actual value realized upon the vesting or future exercise of the related stock-based awards and, therefore, is not used by management to assess the core profitability of our business operations.

      (iii) Acquisition/divestiture related items. In connection with certain of our business combinations and/or divestitures, we incur significant expenses that we would not have otherwise incurred as part of our business operations. These expenses include, among other things, compensation expenses, professional fees and other direct expenses, concurrent restructuring activities and divestiture activities, including employee severance and other exit costs, bridge financing costs, costs related to integration activities, debt forgiveness, changes to the fair value of contingent consideration related to the acquired company, and amortization of the fair value difference of below-market value assets arising from arrangements entered into or acquired in conjunction with an acquisition. We also recognize the gains and losses from the mark-up of equity or cost method investments to fair value upon obtaining control through acquisition. We exclude these items because they are related to acquisitions and divestitures and have no direct correlation to the core operation of our business. Further, because we do not acquire or divest businesses on a predictable cycle and the terms of each transaction can vary significantly and are unique to each transaction, we believe it is useful to exclude such expenses when looking for a consistent basis for comparison across accounting periods.

      (iv) Restructuring charges. We initiate restructuring activities to align our costs to our operating plans and business strategies based on then-current economic conditions, and such activities have a specific and defined term. Restructuring costs generally include severance and other termination benefits related to voluntary retirement programs, involuntary headcount reductions and facilities closures. Such restructuring costs include elimination of operational redundancy, permanent reductions in workforce and facilities closures and, therefore, are not considered by us to be a part of the core operation of our business and are not used by management when assessing the core profitability and performance of our business operations.

      (v) Gains (losses) on the sale of strategic investments. We exclude gains and losses on the sale of equity investments in privately held companies because we do not believe they are reflective of our core business and operating results.

      (vi) Deferred compensation. We exclude changes in the fair value of our non-qualified deferred compensation plan because we do not use these to assess the core profitability of our business operations.

      (vii) Income tax effect of non-GAAP pre-tax adjustments. Excluding the income tax effect of non-GAAP pre-tax adjustments from the provision for income taxes assists investors in understanding the tax provision associated with those adjustments and the effect on net income. We utilize an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect our normal operations, and to more closely align our tax rate with our expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of our historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, we have elected to adopt a non-GAAP tax rate of 16% for fiscal year 2025.

      About Synopsys
      Catalyzing the era of pervasive intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.

      © 2025 Synopsys, Inc. All rights reserved. Synopsys, the Synopsys logo, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.

      INVESTOR CONTACT:
      Trey Campbell
      Synopsys, Inc.
      650-584-4289
      [email protected]

      EDITORIAL CONTACT:
      Cara Walker
      Synopsys, Inc.
      650-584-5000
      [email protected]

      SOURCE Synopsys, Inc.

      Modal title

      Also from this source

      Synopsys Initiates $1 Billion Accelerated Share Repurchase Agreement

      Synopsys Initiates $1 Billion Accelerated Share Repurchase Agreement

      Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase Bank,...

      Synopsys Details Growth Strategy and Long-term Financial Model at 2026 Investor Day

      Synopsys Details Growth Strategy and Long-term Financial Model at 2026 Investor Day

      Synopsys, Inc. (NASDAQ: SNPS) today detailed its long-term growth strategy and sustainable long-term financial model at its 2026 Investor Day in New...

      More Releases From This Source

      Explore

      Computer & Electronics

      Computer & Electronics

      Electronic Components

      Electronic Components

      Computer Software

      Computer Software

      Electronic Design Automation

      Electronic Design Automation

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.